EVALUATION OF THE CALCIUM-PHOSPHOR HOMEOSTASIS AND PROINFLAMMATORY STATUS OF RECIPIENTS WITH CALCIUM DEGENERATION OF CARDIAC VALVES PROSTHESES

Aim. To study calcium-phosphor homeostasis and proinflammatory status of the cardiac valves bioprostheses (BP) recipients related to their interference with calcium degeneration of biomaterials.

Material and methods. A retrospective assessment was performed of the calcium-phosphor metabolism and markers of non-specific inflammatory response in recipients of BP in mitral position: with histologically confirmed calcification — group I (n=22) and with normal morphology and prosthesis function — group II (n=48).

Results. In patients with BP degeneration, comparing to the recipients of biological prostheses with normal function at the background of moderate hypovitaminosis D (34,0 [21,0; 49,4] versus 40 [27,2; 54,0] pmol/L, р>0,05), osteoprotegerine deficiency (82,5 [44,2; 115,4] versus 113,5 [65,7; 191,3] pg/ml, р>0,05) and osteopontine (4,5 [3,3; 7,7] versus 5,2 [4,1; 7,2] ng/ml, р>0,05) there was statistically significant decrease of the bone isoenzyme of alkaline phosphatase (17,1 [12,2; 21,4] versus 22,3 [15,5; 30,5] E/L, р=0,01), and significant decrease of IL-8 (9,74 [9,19; 10,09] pg/ml versus 13,17 [9,72; 23,1] pg/ml, р=0,045) with general increase of proinflammatory serum markers activity.

Conclusion. Into the group of probable predictors determining the tempos of BP calcification, the following could be included: specifics of recipient metabolic status defined by the activity of bone resorption processes, and local and systemic inflammation.

calcification, bioprostheses, inflammation, calcium-phosphor homeostasis

1. Thiene G, Valente M. Anticalcification strategies to increase bioprosthetic valve durability. J Heart Valve Dis. 2011; 20(1): 37-44.

2. Aronov WS. Osteoporosis, osteopenia and atherosclerotic vascular disease. Arch Med Sci. 2011; 7(1): 21-6.

3. Hjortnaes J, Butcher J, Figueiredo JL, et al. Arterial and aortic valve calcification inversely correlates with osteoporotic bone remodelling: a role for inflammation. Eur Heart J. 2010; 31(16): 1975-84.

4. Sophie EP, Aikawa E. Molecular imaging insights into early inflammatory stages of arterial and aortic valve calcification. Circ Res. 2011; 108: 1381-91.

5. Mahjoub Y, Mathieu P, Senechal M, et al. ApoB/ApoA ratio is associated with increased risk bioprosthetic valve degeneration. J Am Coll Cardiol. 2013; 61(7): 752-61.

6. Briand M, Pibarot P, Despres JP, et al. Metabolic syndrome is associated with faster degeneration of bioprosthetic valves. Circulation. 2006; 114: 1512-7.

7. Nollert G, Miksch J, Kreuzer E, et al. Risk factors for atherosclerosis and the degeneration of pericardial valves after aortic valve replacement. J Thorac Cardiovasc Surg. 2003; 126: 965-8.

8. Schoen FJ, Levy RJ. Calcification of tissue heart valve substitutes: progress toward understanding and prevention. Ann Thorac Surg 2005; 79: 1072-80.

9. Wilhelmi MH, Mertsching H, Wilhelmi M, et al. Role of inflammation in allogeneic and xenogeneic heart valve degeneration: immunohistochemical evaluation of inflammatory endothelial cell activation. J Heart Valve Dis. 2003; 12: 520-6.

10. Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab. 2004; 286: 686-96.

11. Hamerman D. Osteoporosis and atherosclerosis: biological linkages and the emergence of dual–purpose therapies. Q J Med. 2005; 98: 467-84.

12. Steitz SA, Speer MY, McKee MD, et al. Osteopontin inhibits mineral deposition and promotes regression of ectopic calcification. Am J Pathol. 2008; 161(6): 2035-46.

13. Yu PJ, Skolnick A, Ferrari G, et al. Correlation between plasma osteopontin levels and aortic valve calcification: Potential insights into the pathogenesis of aortic valve calcification and stenosis. Journal of Thoracic and Cardiovascular Surgery. 2009; 138 (1): 196-9.

14. Raaz-Schrauder D, Klinghammer L, Baum C, et al. Association of systemic inflammation markers with the presence and extent of coronary artery calcification. Cytokine. 2012; 57(2): 251-7.

15. Parvathy T, Divakaran N, Lalithakunjamma R, et al. Pathological effects of processed bovine pericardial. Artificial Organs. 2013; 37(7): 600-5.